Skip to main content
Clinical Trials/NCT03145493
NCT03145493CompletedNot Applicable

(L'Effet Des Drains Aspiratifs en Arthroplastie du Genou Avec l'Utilisation de l'Acide Tranexamique)

Centre hospitalier de l'Université de Montréal (CHUM)1 site in 1 country140 target enrollmentStarted: October 3, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
140
Locations
1
Primary Endpoint
Hb variation

Study Overview

Brief Summary

Problem Suction drains during TKA present certain costs to the health system and requires additional nursing care. There is no clear evidence that supports their use, and no studies so far have compared blood loss in patients with or without drains when TA is administered during TKA.

Hypothesis During total knee arthroplasty, the postoperative blood loss, measured by hemoglobin level, will be lower when no drains are used.

Method

  • Randomized controlled trial
  • Monocentric, 3 surgeons
  • Randomisation by sealed envelopes

Detailed Description

During total knee arthroplasty, the postoperative blood loss, measured by hemoglobin level, will be lower when no drains are used.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Unilateral primary total knee arthroplasty

Exclusion Criteria

  • •TKA revision
  • •Bilateral TKA
  • •Patients that refuse transfusions
  • •Contraindication to tranexamic acid use: allergy, thromboembolic history
  • •Coagulopathy
  • •Kidney failure

Arms & Interventions

Usage of suction drains

Experimental

Usage of suction drains

Intervention: drainage (Device)

No usage of suction drains

No Intervention

No usage of suction drains

Outcomes

Primary Outcomes

Hb variation

Time Frame: 3 days after surgey

Difference between Hb levels measured in pre-op and on postoperatively day 3.

Secondary Outcomes

  • Number of blood transfusions(from admission till 2 months after surgery)
  • Range of motion of knee(preoperative visit , at the end of surgery, and on post-op day 3)
  • additional surgery(from admission till 2 months after surgery)
  • Clinical results(from admission till 2 months after surgery)
  • Cost of suction drains(from admission till 2 months after surgery)
  • Length of hospital stay(from admission till 2 months after surgery)
  • KOOS score(At preoperative visit and post-operative visit of six weeks after surgery)
  • Cost of blood transfusions(from admission till 2 months after surgery)
  • SF-12 score(At preoperative visit and post-operative visit of six weeks after surgery)

Investigators

Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials